To survey patients after successful treatment, researchers developed a prediction model for recurrent dysplasia after eradication of Barrett esophagus.
All articles by Colby Strong
Living-Donor Liver Transplant Is an Independent Protective Factor of Reduced Mortality in Patients With HCC
Investigators assessed the benefit of a potential living donor on survival in patients with hepatocellular carcinoma on a waiting list for a liver transplant.
A team of investigators conducted a meta-analysis to assess outcomes following Helicobacter pylori eradication therapy as first-line treatment for patients with H pylori-negative gastric MALT lymphoma.
Latest News Your top articles for ThursdayFor More Personalized News
Haymarket Medical NetworkTop Picks
Continuing Medical Education (CME/CE) Courses